Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02807051
Recruitment Status : Completed
First Posted : June 21, 2016
Last Update Posted : January 29, 2020
Information provided by (Responsible Party):
CTI BioPharma

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014